Stocks to Watch: Boeing, Vera Bradley, Molecular Templates

Dow Jones
12 Oct 2024
 

By Connor Hart

 

Boeing will cut 10% of its global workforce, or roughly 17,000 jobs, and warned of deeper losses in its operations. In addition to the layoffs, the company will further delay the launch of a new airplane, the 777X, which is already years behind schedule. It will also discontinue the 767 cargo plane. Shares fall 1.8%, to $148.25, in after-hours trading.

Vera Bradley's board unanimously approved the adoption of a limited duration shareholder rights plan. Under the plan, one right would be issued for each outstanding share of the company's common stock if a person, entity or group acquires beneficial ownership of 15% or more of the company's shares in a transaction not approved by the board. The poison pill comes as macroeconomic headwinds continue to dampen the company's turnaround efforts. Shares rise 7.3%, to $5.56, in postmarket trading.

Molecular Templates' board unanimously approved the liquidation and wind up of the company. The biotechnology company, which began exploring strategic alternatives with third-party advisers more than a year ago, said that there are no other options currently available. The company doesn't expect its stockholders will receive value for their shares in connection with a dissolution. Shares tumble 18%, to $1.21, in after-hours trading.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

October 11, 2024 18:08 ET (22:08 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10